Breadcrumbs Section. Click here to navigate to respective pages.
Book

Book
Silver Nanoparticles for Antibacterial Devices
DOI link for Silver Nanoparticles for Antibacterial Devices
Silver Nanoparticles for Antibacterial Devices book
Silver Nanoparticles for Antibacterial Devices
DOI link for Silver Nanoparticles for Antibacterial Devices
Silver Nanoparticles for Antibacterial Devices book
Get Citation
ABSTRACT
Since the potential toxicity of silver nanoparticles (Ag NPs) has raised serious concerns in the biomaterials and biomedical engineering community, Silver Nanoparticles for Antibacterial Devices: Biocompatibility and Toxicity brings together the synthesis, the physicochemical properties and the biological actions of Ag NPs, as well as the clinical demands for fabricating antibacterial medical devices, discussing how to suppress the side effects of nanomaterials and how to impart to them the selective toxicity. This book presents the two primary paradigms that have emerged in probing the antibacterial applications of Ag NPs, i.e. the active attacking releasing way and the conservative defending approach by taking advantage of various short-range actions; it shows readers how the ways in which Ag NPs have behaved can be engineered purposively.
With contributions from leading international experts and extensive references listed in each chapter, this volume provides the general principles on controlling the physicochemical behaviors of nanomaterials and managing their toxicity risks.
TABLE OF CONTENTS
section I|2 pages
Synthesis and Assembling
chapter 1|34 pages
Bioinspired Synthesis of Silver Nanoparticles: Characterisation, Mechanism and Applications
chapter 2|18 pages
Tuning the Properties of Silver Monolayers for Biological Applications
chapter 3|30 pages
Synergistic Antimicrobial Activity of Silver and Chitosan
chapter 4|26 pages
Titania Nanotubes as Silver Nanoparticle Carriers to Prevent Implant-Associated Infection
chapter 5|22 pages
Polymer–Silver Nanocomposites: Preparation, Characterisation and Antibacterial Mechanism
section II|2 pages
The Risk of Silver
chapter 6|30 pages
Dissolution of Silver Nanoparticles
chapter 7|28 pages
Silver as an Antimicrobial Agent: The Resistance Issue
chapter 8|18 pages
The Risks of Silver Nanoparticles to the Human Body
chapter 9|16 pages
Immunomodulatory Activities of Silver Nanoparticles (AgNPs) in Human Neutrophils
section III|2 pages
Techniques and Concepts for Risk Control
chapter 10|52 pages
Evaluating the Interactions of Silver Nanoparticles and Mammalian Cells Based on Biomics Technologies
chapter 11|20 pages
Methods and Tools for Assessing Nanomaterials and Uses and Regulation of Nanosilver in Europe
section IV|2 pages
Clinical Demands